ESMO'22 Recommended Abstracts:
in RENAL CANCERS
![](img/cancer/figlin.jpg)
![](img/space.jpg)
These recommended abstracts from ESMO 2022 Annual meeting have been selected by Robert A. Figlin, MD, Editor-in- Chief of the Kidney Cancer Journal. The chosen abstracts provided here highlight some of the most important trends in ongoing trials and reflect the foremost research and strategies from latest clinical trials that impact the current standard of care in renal cancer.
Abstract Titles
ABSTRACT LBA8:
![](img/2022/2022q3/LBA8.jpg)
![](img/space.jpg)
ABSTRACT 14480:
![](img/2022/2022q3/14480.jpg)
![](img/space.jpg)
ABSTRACT 14470:
![](img/2022/2022q3/14470.jpg)
![](img/space.jpg)
ABSTRACT 1464P:
![](img/2022/2022q3/1464P.jpg)
![](img/space.jpg)
ABSTRACT 1466P
![](img/2022/2022q3/1466P.jpg)
![](img/space.jpg)
ABSTRACT 1450MO
![](img/2022/2022q3/1450MO.jpg)
![](img/space.jpg)
ABSTRACT 1677P
![](img/2022/2022q3/1677P.jpg)
![](img/space.jpg)
ABSTRACT 1451MO
![](img/2022/2022q3/1451MO.jpg)
![](img/space.jpg)
ABSTRACT 1461P
![](img/2022/2022q3/1461P.jpg)
ABSTRACT 1453P
![](img/2022/2022q3/1453P.jpg)
![](img/space.jpg)
![](img/space.jpg)
![](img/space.jpg)
![](img/space.jpg)